Skip to main content
. Author manuscript; available in PMC: 2014 Jan 6.
Published in final edited form as: Histopathology. 2012 Sep 11;62(2):10.1111/j.1365-2559.2012.04344.x. doi: 10.1111/j.1365-2559.2012.04344.x

Figure 1.

Figure 1

Immunohistochemical staining in primary TNBC. (A) and (B), a carcinoma with positive staining for both GCDFP-15 (A) and MAM (B). (C) and (D), a carcinoma with positive staining for GCDFP-15 (C) and negative staining for MAM (D). (E) and (F), a metaplastic carcinoma with focal staining for GCDFP-15 (E) and positive staining for MAM (F) in the carcinoma component (lower left) but negative staining for both markers in the adjacent sarcomatoid areas. E inset, a hematoxylin and eosin stain of the tumor. (Original magnifications: A, B, E, E inset, F, ×200; C, D, ×100)